SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-003566
Filing Date
2009-03-11
Accepted
2009-03-11 12:11:22
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c82250e10vk.htm 10-K 918419
2 EXHIBIT 3.4 c82250exv3w4.htm EX-3.4 5077
3 EXHIBIT 10.36 c82250exv10w36.htm EX-10.36 168522
4 EXHIBIT 21.1 c82250exv21w1.htm EX-21.1 965
5 EXHIBIT 23.1 c82250exv23w1.htm EX-23.1 4732
6 EXHIBIT 31.1 c82250exv31w1.htm EX-31.1 5989
7 EXHIBIT 31.2 c82250exv31w2.htm EX-31.2 5948
8 EXHIBIT 32.1 c82250exv32w1.htm EX-32.1 2507
9 EXHIBIT 32.2 c82250exv32w2.htm EX-32.2 2516
10 GRAPHIC c82250c8225001.gif GRAPHIC 12928
  Complete submission text file 0001362310-09-003566.txt   1134151
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 09671727
SIC: 2835 In Vitro & In Vivo Diagnostic Substances